Florent Puisset

Publications

Article dans une revue (38)

Oncology pharmacy practice: Key insights, challenges, and perspectives – A position paper from the French Society for Oncology Pharmacy (SFPO) Florence Ranchon,Florian Slimano,Isabelle Borget,Mathieu Boulin,Christophe Bardinet al. Annales Pharmaceutiques Françaises, 2025, 83 (6), pp.1040-1052. ⟨10.1016/j.pharma.2025.07.005⟩ Article dans une revue hal-05470190v1
A comparative study of gellan gum and xanthan gum versus commercial vehicles as pharmaceutical thickening agents in oral suspensions Pauline Claraz,Luc Fillaudeau,Chloé Jadoul,Thomas Storme,Coralie Guillemotet al. European Journal of Pharmaceutics and Biopharmaceutics, 2025, 207, pp.114622. ⟨10.1016/j.ejpb.2024.114622⟩ Article dans une revue hal-04875081v1
Cartographie française des activités de pharmacie clinique réalisées auprès des patients âgés atteints de cancer : une enquête SFPO-SFPC Chloé Herledan,Anne Toulemonde,Mathilde Sturmia,Anne-Laure Clairet,Aurélie Terrier-Lengletet al. Bulletin du Cancer, 2025, 112 (5), pp.495-504. ⟨10.1016/j.bulcan.2024.12.017⟩ Article dans une revue hal-05054527v1
Exposure toxicity of venetoclax in acute myeloid leukemia patients in the real-life setting: impact of high exposure on delayed neutropenia Florent Puisset,Emmanuel Raffoux,Lionel Ades,Tony Huynh,Raphaël Itzyksonet al. Haematologica, 2024, ⟨10.3324/haematol.2024.286062⟩ Article dans une revue hal-04920565v1
Exposure-response relationship of cabozantinib in patients with metastatic renal cell carcinoma treated in routine care Benoit Blanchet,Alexandre Xu-Vuilard,Anne Jouinot,Florent Puisset,David Combarelet al. British Journal of Cancer, 2024, 130 (6), pp.961-969. ⟨10.1038/s41416-024-02585-y⟩ Article dans une revue hal-04821736v1
Investigating the clinical impact of dose‐banding for weekly paclitaxel in patients with breast cancer: A retrospective and monocentric study Florent Puisset,Félicien Le Louedec,Florence Dalenc,Lorène Verguet,Eleonora de Maioet al. British Journal of Clinical Pharmacology, 2023, 89 (7), pp.2283-2294. ⟨10.1111/bcp.15702⟩ Article dans une revue hal-04920299v1
Investigating the clinical impact of dose‐banding for weekly paclitaxel in patients with breast cancer: A retrospective and monocentric study Florent Puisset,Félicien Le Louedec,Florence Dalenc,Lorène Verguet,Eleonora de Maioet al. British Journal of Clinical Pharmacology, 2023, 89 (7), pp.2283-2294. ⟨10.1111/bcp.15702⟩ Article dans une revue hal-04972257v1
Considering the Oral Bioavailability of Protein Kinase Inhibitors: Essential in Assessing the Extent of Drug–Drug Interaction and Improving Clinical Practice Félicien Le Louedec,Florent Puisset,Etienne Chatelut,Michel Tod Clinical Pharmacokinetics, 2023, 62 (1), pp.55-66. ⟨10.1007/s40262-022-01200-8⟩ Article dans une revue hal-04973559v1
Infectious risk when prescribing rituximab in patients with hypogammaglobulinemia acquired in the setting of autoimmune diseases Xavier Boumaza,Margaux Lafaurie,Emmanuel Treiner,Ondine Walter,Gregory Pugnetet al. International Immunopharmacology, 2023, 120, pp.110342. ⟨10.1016/j.intimp.2023.110342⟩ Article dans une revue hal-04972256v1
Therapeutic Drug Monitoring of Tyrosine Kinase Inhibitors in the Treatment of Advanced Renal Cancer Florent Puisset,Mourad Mseddi,Loïc Mourey,Damien Pouessel,Benoit Blanchetet al. Cancers, 2023, 15 (1), pp.313. ⟨10.3390/cancers15010313⟩ Article dans une revue hal-04973562v1
Retrospective, real‐life study of venetoclax plus azacitidine or low‐dose cytarabine in French patients with acute myeloid leukemia ineligible for intensive chemotherapy Louise Laloi,Natacha Chaumard Billotey,Pierre-Yves Dumas,Franciane Paul,Alban Villateet al. Cancer Medicine, 2022, 12 (6), pp.7175-7181. ⟨10.1002/cam4.5459⟩ Article dans une revue hal-04972259v1
Easy and reliable maximum a posteriori Bayesian estimation of pharmacokinetic parameters with the open‐source R package mapbayr Félicien Le Louedec,Florent Puisset,Fabienne Thomas,Étienne Chatelut,Mélanie White-Koning CPT: Pharmacometrics and Systems Pharmacology, 2021, 10 (10), ⟨10.1002/psp4.12689⟩ Article dans une revue hal-04821229v1
Life-threatening complications after high-dose methotrexate and the benefits of glucarpidase as salvage therapy: a cohort study of 468 patients Chloé Medrano,Lucie Obéric,Florent Puisset,Christian Récher,Delphine Larrieu-Cironet al. Leukemia & lymphoma, 2021, 62 (4), pp.846 - 853. ⟨10.1080/10428194.2020.1846733⟩ Article dans une revue inserm-04791818v1
Limited Sampling Strategy for Determination of Ibrutinib Plasma Exposure: Joint Analyses with Metabolite Data Félicien Le Louedec,Fanny Gallais,Fabienne Thomas,Mélanie White-Koning,Ben Allalet al. Pharmaceuticals, 2021, 14 (2), pp.162. ⟨10.3390/ph14020162⟩ Article dans une revue inserm-04791320v1
Easy and reliable maximum a posteriori Bayesian estimation of pharmacokinetic parameters with the open‐source R package mapbayr Félicien Le Louedec,Florent Puisset,Fabienne Thomas,Étienne Chatelut,Mélanie White-Koning CPT: Pharmacometrics and Systems Pharmacology, 2021, 10 (10), pp.1208-1220. ⟨10.1002/psp4.12689⟩ Article dans une revue hal-04972260v1
Body Surface Area Dosing of High-Dose Methotrexate Should Be Reconsidered, Particularly in Overweight, Adult Patients Fanny Gallais,Lucie Oberic,Stanislas Faguer,Suzanne Tavitian,Thierry Lafontet al. Therapeutic Drug Monitoring, 2021, 43 (3), pp.408-415. ⟨10.1097/FTD.0000000000000813⟩ Article dans une revue hal-04973414v1
Severe toxicity of capecitabine in a patient with DPD deficiency after a safe FEC-100 experience: why we should test DPD deficiency in all patients before high-dose fluoropyrimidines Maud Maillard,Audrey Eche-Gass,Mony Ung,Aurélie Brice,Sabrina Marsiliet al. Cancer Chemotherapy and Pharmacology, 2021, 87 (4), pp.579-583. ⟨10.1007/s00280-021-04233-1⟩ Article dans une revue hal-04972262v1
Involvement of Pazopanib and Sunitinib Aldehyde Reactive Metabolites in Toxicity and Drug–Drug Interactions in Vitro and in Patient Samples Marie-Noelle Paludetto,Jean-Luc Stigliani,Anne Robert,Vania Bernardes-Génisson,Etienne Chatelutet al. Chemical Research in Toxicology, 2020, 33 (1), pp.181-190. ⟨10.1021/acs.chemrestox.9b00205⟩ Article dans une revue hal-02448694v1
Brentuximab vedotin in real life, a seven year experience in patients with refractory/relapsed CD30+ T cell lymphoma Lucie Oberic,Faustine Delzor,Caroline Protin,Sophie Perriat,Camille Laurentet al. Journal of Oncology Pharmacy Practice, 2020, 27 (7), pp.1730-1735. ⟨10.1177/1078155220968615⟩ Article dans une revue hal-04920640v1
Formulae recently proposed to estimate renal glomerular filtration rate improve the prediction of carboplatin clearance Mélanie White-Koning,Marie Noëlle Paludetto,Félicien Le Louedec,Laurence Gladieff,Christine Chevreauet al. Cancer Chemotherapy and Pharmacology, 2020, 85 (3), pp.585-592. ⟨10.1007/s00280-019-04020-z⟩ Article dans une revue hal-04920331v1
Assessment of efficacy of postinfusion tubing flushing in reducing risk of cytotoxic contamination Pauline Claraz,Isabelle Riff,Charlotte Vert,Elina Wolff,Sophie Perriatet al. American Journal of Health-System Pharmacy, 2020, 77 (22), pp.1866-1873. ⟨10.1093/ajhp/zxaa357⟩ Article dans une revue hal-04920636v1
Association between clinically relevant toxicities of pazopanib and sunitinib and the use of weak CYP3A4 and P-gp inhibitors Camille Azam,Pauline Claraz,Christine Chevreau,Camille Vinson,Ewa Cotturaet al. European Journal of Clinical Pharmacology, 2020, 76 (4), pp.579-587. ⟨10.1007/s00228-020-02828-w⟩ Article dans une revue hal-04973416v1
Life-threatening complications after high-dose methotrexate and the benefits of glucarpidase as salvage therapy: a cohort study of 468 patients Chloé Medrano,Lucie Oberic,Florent Puisset,Christian Recher,Delphine Larrieu-Cironet al. Leukemia & lymphoma, 2020, 62 (4), pp.846-853. ⟨10.1080/10428194.2020.1846733⟩ Article dans une revue hal-04972263v1
Formulae recently proposed to estimate renal glomerular filtration rate improve the prediction of carboplatin clearance Melanie White-Koning,Marie Noëlle Paludetto,Félicien Le Louedec,Laurence Gladieff,Christine Chevreauet al. Cancer Chemotherapy and Pharmacology, 2020, 85 (3), pp.585-592. ⟨10.1007/s00280-019-04020-z⟩ Article dans une revue hal-04973418v1
Involvement of Pazopanib and Sunitinib Aldehyde Reactive Metabolites in Toxicity and Drug–Drug Interactions in Vitro and in Patient Samples Marie-Noëlle Paludetto,Jean-Luc Stigliani,Anne Robert,Vania Bernardes-Génisson,Etienne Chatelutet al. Chemical Research in Toxicology, 2019, 33 (1), pp.181-190. ⟨10.1021/acs.chemrestox.9b00205⟩ Article dans une revue hal-04973511v1
Identifying the reactive metabolites of tyrosine kinase inhibitors in a comprehensive approach: Implications for drug‐drug interactions and hepatotoxicity Marie-Noëlle Paludetto,Florent Puisset,Etienne Chatelut,Cécile Arellano,Marie‐noëlle Paludetto Medicinal Research Reviews, 2019, 39 (6), pp.2105-2152. ⟨10.1002/med.21577⟩ Article dans une revue hal-04973564v1
Simultaneous monitoring of pazopanib and its metabolites by UPLC–MS/MS Marie-Noëlle Paludetto,Florent Puisset,Félicien Le Louedec,Ben Allal,Thierry Lafontet al. Journal of Pharmaceutical and Biomedical Analysis, 2018, 154, pp.373-383. ⟨10.1016/j.jpba.2018.03.013⟩ Article dans une revue istex hal-04970346v1
Metalloporphyrin-Catalyzed Oxidation of Sunitinib and Pazopanib, Two Anticancer Tyrosine Kinase Inhibitors: Evidence for New Potentially Toxic Metabolites Marie-Noëlle Paludetto,Christian Bijani,Florent Puisset,Vania Bernardes-Génisson,Cécile Arellanoet al. Journal of Medicinal Chemistry, 2018, 61 (17), pp.7849-7860. ⟨10.1021/acs.jmedchem.8b00812⟩ Article dans une revue hal-04973547v1
Metalloporphyrin-catalyzed oxidation of sunitinib and pazopanib, two anticancer tyrosine kinase inhibitors: Evidence for new potentially toxic metabolites Marie-Noëlle Paludetto,Christian Bijani,Florent Puisset,Vania Bernardes-Génisson,C. Arellanoet al. Journal of Medicinal Chemistry, 2018, 61 (17), pp.7849-7860. ⟨10.1021/acs.jmedchem.8b00812⟩ Article dans une revue hal-01952871v1
Safety of oral hydration after cisplatin infusion in an outpatient lung cancer unit Florent Puisset,Laurence Bigay-Game,Marie Noëlle Paludetto,Audrey Martel,Sophie Perriatet al. Supportive Care in Cancer, 2018, 27 (5), pp.1679-1686. ⟨10.1007/s00520-018-4415-7⟩ Article dans une revue hal-04970347v1
Standardization of chemotherapy and individual dosing of platinum compounds. Florent Puisset,Antonin Schmitt,Etienne Chatelut Anticancer Research, 2014, 34 (1), pp.465-70 Article dans une revue hal-04970342v1
The Scientific Basis of Body Surface Area–Based Dosing E Chatelut,F Puisset Clinical Pharmacology and Therapeutics, 2014, 95 (4), pp.359-361. ⟨10.1038/clpt.2014.7⟩ Article dans une revue istex hal-04970344v1
Population pharmacokinetics of rituximab with or without plasmapheresis in kidney patients with antibody‐mediated disease Florent Puisset,Mélanie White-Koning,Nassim Kamar,Antoine Huart,Frédérique Habereret al. British Journal of Clinical Pharmacology, 2013, 76 (5), pp.734-740. ⟨10.1111/bcp.12098⟩ Article dans une revue hal-04970340v1
Dose banding as an alternative to body surface area-based dosing of chemotherapeutic agents E Chatelut,M White-Koning,R Hj Mathijssen,F Puisset,S Bakeret al. British Journal of Cancer, 2012, 107 (7), pp.1100-1106. ⟨10.1038/bjc.2012.357⟩ Article dans une revue hal-04970339v1
Clinical pharmacodynamic factors in docetaxel toxicity F Puisset,J Alexandre,J-M Treluyer,V Raoul,H Rochéet al. British Journal of Cancer, 2007, 97 (3), pp.290-296. ⟨10.1038/sj.bjc.6603872⟩ Article dans une revue hal-04970337v1
Dexamethasone as a probe for CYP3A4 metabolism: evidence of gender effect F. Puisset,E. Chatelut,A. Sparreboom,J.-P. Delord,D. Bercheryet al. Cancer Chemotherapy and Pharmacology, 2006, 60 (2), pp.305-308. ⟨10.1007/s00280-006-0385-4⟩ Article dans une revue istex hal-04970336v1
Dexamethasone as a probe for vinorelbine clearance Florent Puisset,Florence Dalenc,Etienne Chatelut,Thierry Cresteil,Isabelle Lochonet al. British Journal of Clinical Pharmacology, 2005, 60 (1), pp.45-53. ⟨10.1111/j.1365-2125.2005.02384.x⟩ Article dans une revue hal-04970324v1
Dexamethasone as a probe for docetaxel clearance Florent Puisset,Etienne Chatelut,Florence Dalenc,Florent Busi,Thierry Cresteilet al. Cancer Chemotherapy and Pharmacology, 2004, 54 (3), pp.265-72. ⟨10.1007/s00280-004-0823-0⟩ Article dans une revue istex hal-04970323v1

Chapitre d'ouvrage (1)

Pharmacocinétique F Puisset Pharmacie Clinique pratique en cancérologie., 2ème édition, elsevier, 2020, 9782294763755 Chapitre d'ouvrage hal-04973604v1

Communication dans un congrès (1)

Resistance of Melanoma to Immune Checkpoint Inhibitors is Overcome by Targeting the Sphingosine Kinase 1 Céline Colacios,Caroline Imbert,Anne Montfort,Marine Fraisse,Elie Marcheteauet al. Canceropole GSO, Canceropole GSO, Nov 2019, Arcachon, France Communication dans un congrès hal-04993281v1